cancer treatment

Developing tiny neural implants to track and treat the world's most difficult diseases

By uniting the fields of cancer neuroscience and bioelectronic medicine, we see the emergence of safe, minimally invasive neural interfaces within oncology. 
A radically new approach within cancer treatment with the potential to change the lives of millions.

1.3 M

people per year
diagnosed with the 4 most aggressive cancers

< 1 in 20

survive diagnosis beyond 5 years

2.1 months

of life added by the average new breakthrough drug brought to market

Leveraging our team's experience within neurotechnology we've discovered a path for targeting some of the world's hardest-to-treat diseases using advanced neural biomarkers and electrotherapies

Learn about SOMA-1

We have developed a new class of implantable device that can measure and disrupt electric fields within the body. Electrical stimulation has the potential to revolutionise treatment for some of the most aggressive diseases. Combining this with electrical recording offers new real-time biomarkers and diagnostic insights which have never before been able to be captured.

Learn More